Virulence attenuation of a UDP-galactose/N-acetylglucosamine β1,4 galactosyltransferase expressing Leishmania donovani promastigote

Glycoconjugate Journal

Volumn 25, Issue 5, 2008, Pages 459-472

  Bhaumik, S K ^a   Singh, M ^a   Basu, R ^a   Bhaumik, S ^a   Roychoudhury, K ^a   Naskar, K ^a   Roy, S ^a   De, T ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

Author keywords

Avirulent Leishmania donovani promastigotes; Galactosylation; UDP Galactose N acetylglucosamine 1 4 Galactosyltransferase

Indexed keywords

GALACTOSE; GALACTOSYLTRANSFERASE; N ACETYLGLUCOSAMINE; PEANUT AGGLUTININ; URIDINE DIPHOSPHATE GALACTOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; GOLGI COMPLEX; IN VITRO STUDY; IN VIVO STUDY; LEISHMANIA DONOVANI; MACROPHAGE; MOLECULAR CLONING; MOUSE; NONHUMAN; PARASITE VIRULENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMASTIGOTE; PROTEIN EXPRESSION;

AGGLUTINATION; ANIMALS; CHROMATOGRAPHY, AFFINITY; CLONE CELLS; GALACTOSIDASES; GALACTOSYLTRANSFERASES; INTRACELLULAR SPACE; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; LIVER; MACROPHAGES; MICE; MICE, INBRED BALB C; NITRITES; PARASITES; PEANUT AGGLUTININ; PROTEIN TRANSPORT; PROTOZOAN PROTEINS; SUPEROXIDES; URIDINE DIPHOSPHATE GALACTOSE; VIRULENCE;

LEISHMANIA DONOVANI; MUS; PISUM SATIVUM; PROTOZOA;

EID: 44449144970     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-007-9098-0     Document Type: Article

References (77)

1. Apweiler, R., Hermjakob, H., Sharon, N.: On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1473, 4-8 (1999)
2. Basu, S., Basu, M., Kyle, J.W., Chon, H.C.: Biosynthesis in vitro of gangliosides containing Gg- and Lc-cores. In: Ledeen, R. (ed.) Gangliosides Structure and Function, pp. 249-261. Plenum Press, New York (1984)
3. Basu, R., Bhaumik, S., Basu, J.M., Naskar, K., De, T., Roy, S.: Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J. Immunol. 174, 7160-7171 (2005)
4. Basu, M., De, T., Das, K.K., Kyle, J.W., Chon, H.C., Schaeper, R.J., Basu, S.: Glycosyltransferases involved in glycolipid biosynthesis. In: Ginsburg, V. (ed.) Methods in Enzymology, pp. 575-607. Academic Press, New York (1987)
5. Belen Carrillo, M., Gao, W., Herrera, M., Alroy, J., Moore, J.B., Beverley, S.M., Pereira, M.A.: Heterologous expression of Trypanosoma cruzi trans-sialidase in Leishmania major enhances virulence. Infect. Immun. 68, 2728-2734 (2000)
6. Beverley, S.M., Turco, S.J.: Lipophosphoglycan (LPG) and the identification of virulence genes in the protozoan parasite Leishmania. Trends. Microbiol. 6, 35-40 (1998)
7. Blackwell, J.M.: Genetic susceptibility to leishmanial infections: studies in mice and man. Parasitology 112, S67-S74 (1996)
8. Bosques, C.J., Tschampel, S.M., Woods, R.J., Imperiali, B.: Effects of glycosylation on peptide conformation: a synergistic experimental and computational study. J. Am. Chem. Soc. 126, 8421-8425 (2004)
9. Bradley, D.: Regulation of Leishmania populations within the host. II. genetic control of acute susceptibility of mice to Leishmania donovani infection. Clin. Exp. Immunol. 30, 130-140 (1977)
10. Brandonisio, O., Panaro, M.A., Marzio, R., Marangi, A., Faliero, S.M., Jirillo, E.: Impairment of the human phagocyte oxidative responses caused Leishmania lipophosphoglycan (LPG): in vitro studies. FEMS Immunol. Med. Microbiol. 8, 57-62 (1994)
11. Buchmüller-Rouiller, Y., Mauël, J.: Impairment of the oxidative metabolism of mouse peritoneal macrophages by intracellular Leishmania spp. Infect Immun. 55, 587-593 (1987)
12. Capul, A.A., Barron, T., Dobson, D.E., Turco, S.J., Beverley, S.M.: Two functionally divergent UDP-Gal nucleotide sugar transporters participate in phosphoglycan synthesis in Leishmania major. J. Biol. Chem. 282, 14006-14017 (2007)
13. Charest, H., Matlashewski, G.: Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene. Mol. Cell Biol. 14, 2975-2984 (1994)
14. Colmenares, M., Corbi, A.L., Turco, S.J., Rivas, L.: The dendritic cell receptor DC- SIGN discriminates among species and life cycle forms of Leishmania. J. Immunol. 172, 1186-1190 (2004)
15. Connaris, S., Greenwell, P.: Glycosidases in mucin-dwelling protozoans. Glycoconj. J. 14, 879-882 (1997)
16. Crocker, P.R., Varki, A.: Siglecs, sialic acids and innate immunity. Trends Immunol. 22, 337-342 (2001)
17. Da Silva, R., Sacks, D.L.: Metacyclogenesis is a major determinant of Leishmania promastigotes virulence and attenuation. Infect. Immun. 55, 2802-2806 (1987)
18. De, T., Roy, S.: Infectivity and attenuation of Leishmania donovani promastigotes: association of galactosyl transferase with loss of parasite virulence. J. Parasitol. 85, 54-59 (1999)
19. Dedet, J.P., Pratlong, F., Lanotte, G., Ravel, C.: Cutaneous leishmaniasis. The parasite. Clin. Dermatol. 17, 261-268 (1999)
20. Descoteaux, A., Luo, Y., Turco, S.J., Beverley, S.M.: A specialized pathway affecting virulence glycoconjugates of Leishmania. Science 269, 1869-1872 (1995)
21. Descoteaux, A., Avila, H.A., Zhang, K., Turco, S.J., Beverley, S.M.: Leishmania LPG3 encodes a GRP94 homolog required for phosphoglycan synthesis implicated in parasite virulence but not viability. EMBO J. 21, 4458-4469 (2002)
22. Esko, J.D., Lindahl, U.: Molecular diversity of heparan sulfate. J. Clin. Invest. 108, 169-173 (2001)
23. Fadden, A.J., Holt, O.J., Drickamer, K.: Molecular characterization of the rat Kupffer cell glycoprotein receptor. Glycobiology 13, 529-537 (2003)
24. Fang, F.C.: Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J. Clin. Invest. 99, 2818-2825 (1997)
25. Fridovich-Keil, J.L.: Galactosemia: the good, the bad, and the unknown. J. Cellular. Physiol. 209, 701-705 (2006)
26. Garami, A., Mehlert, A., Ilg, T.: Glycosylation defects and virulence phenotypes of Leishmania mexicana phosphomannomutase and dolicholphosphate- mannose synthase gene deletion mutants. Mol. Cell. Biol. 21, 8168-8183 (2001)
27. Gradoni, L., Gramiccia, M.: Leishmania infantum tropism: strain genotype or host immune status? Parasitol. Today 10, 264-267 (1994)
28. Gramiccia, M., Gradoni, L., Angelici, M.C.: Epidemiology of Mediterranean leishmaniasis by Leishmania infantum: isoenzyme and kDNA analysis for the identification of parasites from man, vectors and reservoirs. NATO-ASI Ser. A Life. Sci. 1, 21-37 (1989)
29. Green, S.J., Crawford, R.M., Hockmeyer, J.T., Meltzer, M.S., Nacy, C.A.: Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J. Imminol. 145, 4290-4297 (1990)
30. Handman, E., Hocking, R.E.: Stage-specific, strain-specific, and cross-reactive antigens of Leishmania species identified by monoclonal antibodies. Infect. Imm. 37, 28-33 (1982)
31. Helenius, A., Aebi, M.: Roles of N-linked glycans in the endoplasmic reticulum. Ann. Rev. Biochem. 73, 1019-1049 (2004)
32. Ilg, T., Craik, D., Currie, G., Multhaup, G., Bacic, A.: Stage-specific Proteophosphoglycan from Leishmania mexicana Amastigotes. Structural characterization of novel mono-, di-, and triphosphorylated phosphodiester- linked oligosaccharides. J. Biol. Chem. 273, 13509-13523 (1998)
33. Jacobson, R.L., Schlein, Y.: Phlebotomus papatasi and Leishmania major parasites express alpha-amylase and alpha-glucosidase. Acta Trop. 78, 41-49 (2001)
34. Jiménez, M., Ferrer-Dufol, M., Cañavate, C., Gutiérrez-Solar, B., Molina, R., Laguna, F., López-Vélez, R., Cercenado, E., Daudén, E., Blázquez, J., de Guevara, C.L., Gómez, J., de la Torre, J., Barros, C., Altés, J., Serra, T., Alvar, J.: Variability of Leishmania (Leishmania) infantum among stocks from immunocompromised, immunocompetent patients and dogs in Spain. FEMS Microbiol. Lett. 131, 197-204 (1995)
35. Kubar, J., Marty, P., Lelievre, A., Quaranta, J.F., Staccini, P., Caroli-Bosc, C., Le Fichoux, Y.: Visceral leishmaniasis in HIV-positive patients: primary infection, reactivation and latent infection. Impact of the CD4+ T-lymphocyte counts. AIDS 12, 2147-2153 (1998)
36. Li, J., Nolan, T.J., Farrell, J.P.: Leishmania major: a clone with low virulence for BALB/c mice elicits a Th1 type response and protects against infection with a highly virulent clone. Exp. Parasitol. 87, 47-57 (1997)
37. Liew, F.Y., Li, Y., Millott, S.: Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145, 4306-4310 (1990)
38. Liew, F.Y., Li, Y., Millott, S.: Tumour necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from L-arginine. Immunology 71, 556-559 (1990)
39. Lowe, J.B.: Glycosylation in the control of selectin counter-receptor structure and function. Immunol. Rev. 186, 19-36 (2002)
40. Mallan, N., Sengupta, G., Dubey, M.L., Sud, A., Ansari, N.A., Salotra, P.: Antigenaemia and antibody response to Leishmania donovani stage-specific antigens and rk39 antigen in human immunodeficiency virus-infected patients. Br. J. Biomed. Sci. 60, 210-216 (2003)
41. McNeely, T.B., Turco, S.J.: Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes. J. Immunol. 144, 2745-2750 (1990)
42. Morell, A.G., Van Den Hamer, C.J.A., Scheinberg, I.H., Ashwell, G.: Physical and chemical studies on ceruloplasmin. IV. Preparation of radioactive, sialic acid-free ceruloplasmin labeled with tritium on terminal D-galactose residues. J. Biol. Chem. 241, 3745-3749 (1966)
43. Mottram, J.C., Brooks, D.R., Combs, G.H.: Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Curr. Opin. Microbiol. 14, 455-460 (1998)
44. Mukhopadhyay, S., Sen, P., Bhattacharyya, S., Majumdar, S., Roy, S.: Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis. Vaccine 84, 291-300 (1999)
45. Mukhopadhyay, S., Bhattacharyya, S., Majhi, R., De, T., Naskar, K., Majumdar, S., Roy, S.: Use of an attenuated leishmanial parasite as an immunoprophylactic and immunotherapeutic agent against murine visceral leishmaniasis. Clin. Diag. Lab. Immunol. 7, 233-240 (2000)
46. Murray, H.W., Berman, J.D., Wright, S.D.: Immunochemotherapy for intracellular Leishmania donovani infection: gamma interferon plus pentavalent antimony. J. Infect. Dis. 157, 973-978 (1988)
47. Murray, H.W., Lu, C.M., Mauze, S., Freeman, S., Moreira, A.L., Kaplan, G., Coffman, R.L.: Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect. Immun. 70, 6284-6293 (2002)
48. Murray, M.W.: Cell-mediated immune response in experimental visceral leishmaniasis. II. Oxygen-dependent killing of intracellular Leishmania donovani amastigotes. J. Immunol. 129, 351-357 (1982)
49. Murray, M.W.: Effect of continuous administration of interferon-gamma in experimental visceral leishmaniasis. J. Infect. Dis. 161, 992-994 (1990)
50. Nader, T., Vince, J.E., McConville, M.J.: Surface determinants of Leishmania parasites and their role in infectivity in the mammalian host. Curr. Mol. Med. 4, 649-665 (2004)
51. Pratlong, F., Dedet, J.P., Marty, P., Portus, M., Deniau, M., Dereure, J., Abranches, P., Reynes, J., Martini, A., Lefebvre, M., et al.: Leishmania-human immunodeficiency virus coinfection in the Mediterranean basin: isoenzymatic characterization of 100 isolates of the Leishmania infantum complex. J. Infect. Dis. 172, 323-326 (1995)
52. Rabinovich, G.A., Baum, L.G., Tinari, N., Paganelli, R., Natoli, C., Liu, F.T., Iacobelli, S.: Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 23, 313-320 (2002)
53. Ralton, J.E., Naderer, T., Piraino, H.L., Bashtannyk, T.A., Callaghan, J.M., McConville, M.J.: Evidence that intracellular beta1-2 mannan is a virulence factor in Leishmania parasites. J. Biol. Chem. 278, 40757-40763 (2003)
54. Ray, J.C.: Cultivation of various Leishmania parasites on solid medium. Ind. J. Med. Res. 20, 355-357 (1932)
55. Roach, T.I., Kiderlen, A.F., Blackwell, J.M.: Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma interferon-lipopolysaccharide-activated macrophages from Lshs and Lshr congenic mouse strains. Infect. Immun. 59, 3935-3944 (1991)
56. Roos, P.H., Kolb-Bachofen, V., Schlepper-Schäfer, J., Monsigny, M., Stockert, R.J., Kolb, H.: Two galactose-specific receptors in the liver with different function. FEBS Lett. 157, 253-256 (1983)
57. Ryan, K.A., Garraway, L.A., Descoteaux, A., Turco, S.J., Beverley, S.M.: Isolation of virulence genes directing surface glycosyl-phosphatidylinositol synthesis by functional complementation of Leishmania. Proc. Natl. Acad. Sci. USA 90, 8609-8613 (1993)
58. Sacks, D.L., da Silva, R.P.: The generation of infective stage Leishmania major promastigotes is associated with the cell-surface expression and release of a developmentally regulated glycolipid. J. Immunol. 139, 3099-3106 (1987)
59. Sacks, D.L., Perkins, P.V.: Identification of an infective stage of Leishmania promastigotes. Science 223, 1417-1419 (1984)
60. Sacks, D.L.: Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135, 564-569 (1985)
61. Salotra, P., Ralhan, R., Sreenivas, G.: Heat-stress induced modulation of protein phosphorylation in virulent promastigotes of Leishmania donovani. Int. J. Biochem. Cell Biol. 32, 309-316 (2000)
62. Saraiva, E.M., Andrade, A.F., Pereira, M.E.: Cell surface carbohydrate of Leishmania mexicana amazonensis: differences between infective and non-infective forms. Eur. J. Cell Biol. 40, 219-225 (1986)
63. Segovia, M., Artero, J.M., Mellado, E., Chance, M.L.: Effects of long-term in vitro cultivation on the virulence of cloned lines of Leishmania major promastigotes. Ann. Trop. Med. Parasitol. 86, 347-354 (1992)
64. Shakarian, A.M., Dwyer, D.M.: Pathogenic leishmania secrete antigenically related chitinases which are encoded by a highly conserved gene locus. Exp. Parasitol. 94, 238-242 (2000)
65. Shiloh, M.U., MacMicking, J.D., Nicholson, S., Brause, J.E., Potter, S., Marino, M., Fang, F., Dinauer, M., Nathan, C.: Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10, 29-38 (1999)
66. Smith, A.E., Helenius, A.: How viruses enter animal cells. Science 304, 237-242 (2004)
67. Spath, G.F., Epstein, L., Leader, B., Singer, S.M., Avila, H.A., Turco, S.J., Beverley, S.M.: Lipophosphoglycan is a virulence factor distinct from related glycoconjugates in the protozoan parasite Leishmania major. Proc. Natl. Acad. Sci. USA 97, 9258-9263 (2000)
68. Stauber, L.A.: Host resistance to the Khartoum strain of Leishmania donovani. Rice Inst. Pamphlets 45, 80-83 (1958)
69. Streit, J.A., Recker, T.J., Filho, F.G., Beverley, S.M., Wilson, M.E.: Protective immunity against the protozoan Leishmania chagasi is induced by subclinical cutaneous infection with virulent but not avirulent organisms. J. Immunol. 166, 1921-1929 (2001)
70. Tolson, D.L., Turco, S.J., Beecroft, R.O., Pearson, T.W.: The immunochemical strusture and surface arrangement of Leishmania donovani lipophosphoglycan determined using monoclonal antibodies. Mol. Biochem. Parasitol. 35, 109-118 (1989)
71. Underhill, D.M.: Toll-like receptors: networking for success. Eur. J. Immunol. 33, 1767-1775 (2003)
72. Wang, C., Eufemi, M., Turano, C., Giartosio, A.: Influence of the carbohydrate moiety on the stability of glycoproteins. Biochem. 35, 7299-7307 (1996)
73. Wei, X.Q., Charles, I.G., Smith, A., Ure, J., Feng, G.J., Huang, F.P., Xu, D., Muller, W., Moncada, S., Liew, F.Y.: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375, 408-411 (1995)
74. Weiss, P., Ashwell, G.: The asialoglycoprotein receptor: properties and modulation by ligand. Prog. Clin. Biol. Res. 300, 169-184 (1989)
75. Wells, L., Hart, G.W.: O-GlcNAc turns twenty: functional implications for Posttranslational modification of nuclear and cytosolic proteins with a sugar. FEBS Lett. 546, 154-158 (2003)
76. Zhang, W.W., Matlashewski, G.: Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A2. Proc. Natl. Acad. Sci. USA 94, 8807-8811 (1997)
77. Zheng, Z., Butler, K.D., Tweten, R.K., Mensa-Wilmot, K.: Endosomes, glycosomes, and glycosylphosphatidylinositol catabolism in Leishmania major. J. Biol. Chem. 279, 42106-42113 (2004)